Cargando…

Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study

OBJECTIVES: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection/colonisation has been reported in hospitals. The clinical characteristics of CRKP infection/colonisation in the intensive care unit (ICU) have received little attention. This study aims to investigate the epidemiology and extent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fei, Zou, Xiaocui, Zhou, Boting, Yin, Tao, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277079/
https://www.ncbi.nlm.nih.gov/pubmed/37308270
http://dx.doi.org/10.1136/bmjopen-2022-065786
_version_ 1785060214234415104
author Wang, Fei
Zou, Xiaocui
Zhou, Boting
Yin, Tao
Wang, Ping
author_facet Wang, Fei
Zou, Xiaocui
Zhou, Boting
Yin, Tao
Wang, Ping
author_sort Wang, Fei
collection PubMed
description OBJECTIVES: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection/colonisation has been reported in hospitals. The clinical characteristics of CRKP infection/colonisation in the intensive care unit (ICU) have received little attention. This study aims to investigate the epidemiology and extent of K. pneumoniae (KP) resistance to carbapenems, the sources of CRKP patients and CRKP isolates, and the risk factors for CRKP infection/colonisation. DESIGN: Retrospective single-centre study. DATA SOURCE: Clinical data were obtained from electronic medical records. PARTICIPANTS: Patients isolated with KP in the ICU from January 2012 to December 2020. MAIN OUTCOME MEASURES: The prevalence and changing trend of CRKP were determined. The extent of KP isolates resistance to carbapenems, the specimen types of KP isolates, and the sources of CRKP patients and CRKP isolates were all examined. The risk factors for CRKP infection/colonisation were also assessed. RESULTS: The rate of CRKP in KP isolates raised from 11.11% in 2012 to 48.92% in 2020. CRKP isolates were detected in one site in 266 patients (70.56%). The percentage of CRKP isolates not susceptible to imipenem increased from 42.86% in 2012 to 98.53% in 2020. The percentage of CRKP patients from general wards in our hospital and other hospitals gradually converged in 2020 (47.06% vs 52.94%). CRKP isolates were mainly acquired in our ICU (59.68%). Younger age (p=0.018), previous admission (p=0.018), previous ICU stay (p=0.008), prior use of surgical drainage (p=0.012) and gastric tube (p=0.001), and use of carbapenems (p=0.000), tigecycline (p=0.005), β-lactams/β-lactamase inhibitors (p=0.000), fluoroquinolones (p=0.033), and antifungal drugs (p=0.011) within the prior 3 months were independent risk factors for CRKP infection/colonisation. CONCLUSIONS: Overall, the rate of KP isolates resistance to carbapenems increased, and the severity of this resistance significantly increased. Intensive and local infection/colonisation control measures are necessary for ICU patients, especially those with risk factors for CRKP infection/colonisation.
format Online
Article
Text
id pubmed-10277079
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102770792023-06-19 Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study Wang, Fei Zou, Xiaocui Zhou, Boting Yin, Tao Wang, Ping BMJ Open Infectious Diseases OBJECTIVES: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection/colonisation has been reported in hospitals. The clinical characteristics of CRKP infection/colonisation in the intensive care unit (ICU) have received little attention. This study aims to investigate the epidemiology and extent of K. pneumoniae (KP) resistance to carbapenems, the sources of CRKP patients and CRKP isolates, and the risk factors for CRKP infection/colonisation. DESIGN: Retrospective single-centre study. DATA SOURCE: Clinical data were obtained from electronic medical records. PARTICIPANTS: Patients isolated with KP in the ICU from January 2012 to December 2020. MAIN OUTCOME MEASURES: The prevalence and changing trend of CRKP were determined. The extent of KP isolates resistance to carbapenems, the specimen types of KP isolates, and the sources of CRKP patients and CRKP isolates were all examined. The risk factors for CRKP infection/colonisation were also assessed. RESULTS: The rate of CRKP in KP isolates raised from 11.11% in 2012 to 48.92% in 2020. CRKP isolates were detected in one site in 266 patients (70.56%). The percentage of CRKP isolates not susceptible to imipenem increased from 42.86% in 2012 to 98.53% in 2020. The percentage of CRKP patients from general wards in our hospital and other hospitals gradually converged in 2020 (47.06% vs 52.94%). CRKP isolates were mainly acquired in our ICU (59.68%). Younger age (p=0.018), previous admission (p=0.018), previous ICU stay (p=0.008), prior use of surgical drainage (p=0.012) and gastric tube (p=0.001), and use of carbapenems (p=0.000), tigecycline (p=0.005), β-lactams/β-lactamase inhibitors (p=0.000), fluoroquinolones (p=0.033), and antifungal drugs (p=0.011) within the prior 3 months were independent risk factors for CRKP infection/colonisation. CONCLUSIONS: Overall, the rate of KP isolates resistance to carbapenems increased, and the severity of this resistance significantly increased. Intensive and local infection/colonisation control measures are necessary for ICU patients, especially those with risk factors for CRKP infection/colonisation. BMJ Publishing Group 2023-06-09 /pmc/articles/PMC10277079/ /pubmed/37308270 http://dx.doi.org/10.1136/bmjopen-2022-065786 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Wang, Fei
Zou, Xiaocui
Zhou, Boting
Yin, Tao
Wang, Ping
Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
title Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
title_full Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
title_fullStr Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
title_full_unstemmed Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
title_short Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
title_sort clinical characteristics of carbapenem-resistant klebsiella pneumoniae infection/colonisation in the intensive care unit: a 9-year retrospective study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277079/
https://www.ncbi.nlm.nih.gov/pubmed/37308270
http://dx.doi.org/10.1136/bmjopen-2022-065786
work_keys_str_mv AT wangfei clinicalcharacteristicsofcarbapenemresistantklebsiellapneumoniaeinfectioncolonisationintheintensivecareunita9yearretrospectivestudy
AT zouxiaocui clinicalcharacteristicsofcarbapenemresistantklebsiellapneumoniaeinfectioncolonisationintheintensivecareunita9yearretrospectivestudy
AT zhouboting clinicalcharacteristicsofcarbapenemresistantklebsiellapneumoniaeinfectioncolonisationintheintensivecareunita9yearretrospectivestudy
AT yintao clinicalcharacteristicsofcarbapenemresistantklebsiellapneumoniaeinfectioncolonisationintheintensivecareunita9yearretrospectivestudy
AT wangping clinicalcharacteristicsofcarbapenemresistantklebsiellapneumoniaeinfectioncolonisationintheintensivecareunita9yearretrospectivestudy